Luca Pastorelli

8PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Rheumatology and arthritisInnate immunityPharmacogenomicsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 10, 2026
Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

|Feb 18, 2026
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Franco Scaldaferri, Federica Di Vincenzo, Marina Aloi

|Apr 25, 2025
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease.

Laura Francesca Pisani, Gugliemo Albertini Petroni, Giorgia Crespi

|Mar 11, 2023
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists.

Olga Maria Nardone, Giovanni Marasco, Loris Riccardo Lopetuso

|Feb 14, 2017
Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion.

Flaminia Cavallaro, Lorena Duca, Laura Francesca Pisani

|Mar 14, 2015
Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function.

Luca Pastorelli, Elena Dozio, Laura Francesca Pisani

Pageof 2

Frequent Collaborators

4 joint publications

Laura Francesca Pisani

3 joint publications

Alessandro Armuzzi

2 joint publications

Lucrezia Laterza

2 joint publications

Lorenzo Bertani